Atlas Trials

Effectiveness of Rifaximin on Preventing Postoperative Recurrence in Crohn's Disease

Clinical trial NCT03185624 · UNKNOWN

Trial details

NCT number
NCT03185624
Sponsor
Sixth Affiliated Hospital, Sun Yat-sen University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Crohn Disease
Start date
2017-07-25
Primary completion
2018-01-31
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.